Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie-Grace Sbergio

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neuro-Oncology|February 15, 2025
The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferasesArun Kumaran Anguraj Vadivel, Sanja Pajovic, Robert Siddaway, et al.
Neuro-Oncology|June 29, 2026
Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline GliomaStefanie-Grace Sbergio, Huazhu Liang, Lucy Chen, et al.
Acta Neuropathologica|September 7, 2022
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade gliomaRobert Siddaway, Laura Canty, Sanja Pajovic, et al.
Nature Communications|July 10, 2024
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironmentAdrian B Levine, Liana Nobre, Anirban Das, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neuro-Oncology|February 15, 2025
The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferasesArun Kumaran Anguraj Vadivel, Sanja Pajovic, Robert Siddaway, et al.
Neuro-Oncology|June 29, 2026
Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline GliomaStefanie-Grace Sbergio, Huazhu Liang, Lucy Chen, et al.
Acta Neuropathologica|September 7, 2022
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade gliomaRobert Siddaway, Laura Canty, Sanja Pajovic, et al.
Nature Communications|July 10, 2024
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironmentAdrian B Levine, Liana Nobre, Anirban Das, et al.
Pageof 1